STAT+: What does DeGette’s loss mean for pharma?
By
John Wilkerson
Source
STATSTAT+: What does DeGette’s loss mean for pharma?statnews.comYou might also wanna read
Denver primary voters to decide if 15-term Rep. Diana DeGette's seniority outweighs calls for change
The article examines U.S. Rep. Diana DeGette's campaign for a 16th term in Congress, focusing on whether her long tenure has been effective.
denverpost.com·18d agoFirst-time candidate Melat Kiros defeats 15-term incumbent Diana DeGette in Colorado's 1st Congressional District primary
First-time candidate and democratic socialist Melat Kiros defeated longtime U.S. Rep. Diana DeGette (68, 15-term incumbent) in Colorado's 1s
denverpost.com·2d agoAIPAC and Big Tech Super PACs Spend $2 Million to Boost Diana DeGette in Colorado Primary Against Socialist Challenger Melat Kiros
AIPAC and big tech-backed super PACs have poured roughly $2 million behind Rep. Diana DeGette ahead of her contentious Democratic primary in
Socialist candidates win Democratic primaries but face hurdles enacting their agenda
The article examines the recent wave of socialist and progressive primary victories in Democratic congressional races, including Melat Kiros

Starmer's US pharma deal criticized as costly, harmful to NHS, and a democratic failure
Guardian columnist Aditya Chakrabortty argues that Keir Starmer's government has pushed through a law enabling a US pharma deal that will ha
Progressive Democrats Score Primary Victories in Colorado, Signaling Leftward Shift Ahead of Midterms
Progressive Democrats achieved significant primary election victories, notably in Colorado where 29-year-old Democratic socialist Melat Kiro

Comments
Sign in to join the conversation.
No comments yet. Be the first.